Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more
Universal Biosensors Inc (UBI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.301x
Based on the latest financial reports, Universal Biosensors Inc (UBI) has a cash flow conversion efficiency ratio of -0.301x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.13 Million) by net assets (AU$7.08 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Universal Biosensors Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Universal Biosensors Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Universal Biosensors Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Biosensors Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kancera AB (publ)
ST:KAN
|
-0.227x |
|
Forbidden Foods Ltd
AU:FFF
|
-0.112x |
|
Oscar Properties Holding AB
ST:OP
|
0.151x |
|
Lord Resources Ltd
AU:LRD
|
-0.317x |
|
Asiabasemetals Inc
V:ABZ
|
-0.004x |
|
Puri Global Sukses Tbk Pt
JK:PURI
|
-0.151x |
|
Alakasa Industrindo Tbk
JK:ALKA
|
0.034x |
|
Mohit Industries Limited
NSE:MOHITIND
|
0.003x |
Annual Cash Flow Conversion Efficiency for Universal Biosensors Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Universal Biosensors Inc from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$17.37 Million | AU$-12.30 Million | -0.708x | +5.51% |
| 2023-12-31 | AU$19.51 Million | AU$-14.62 Million | -0.749x | -32.99% |
| 2022-12-31 | AU$26.09 Million | AU$-14.70 Million | -0.563x | -57.19% |
| 2021-12-31 | AU$27.61 Million | AU$-9.90 Million | -0.358x | -64.20% |
| 2020-12-31 | AU$37.98 Million | AU$-8.29 Million | -0.218x | -129.81% |
| 2019-12-31 | AU$45.39 Million | AU$33.24 Million | 0.732x | +2003.00% |
| 2018-12-31 | AU$50.67 Million | AU$1.76 Million | 0.035x | -94.88% |
| 2017-12-31 | AU$12.77 Million | AU$8.69 Million | 0.681x | +27.96% |
| 2016-12-31 | AU$13.25 Million | AU$7.05 Million | 0.532x | +285.32% |
| 2015-12-31 | AU$13.26 Million | AU$1.83 Million | 0.138x | +150.33% |
| 2014-12-31 | AU$19.74 Million | AU$-5.41 Million | -0.274x | +51.04% |
| 2013-12-31 | AU$29.68 Million | AU$-16.63 Million | -0.560x | -568.20% |
| 2012-12-31 | AU$39.37 Million | AU$-3.30 Million | -0.084x | +58.99% |
| 2011-12-31 | AU$35.02 Million | AU$-7.16 Million | -0.204x | -50.48% |
| 2010-12-31 | AU$47.22 Million | AU$-6.41 Million | -0.136x | -218.81% |
| 2009-12-31 | AU$51.31 Million | AU$5.87 Million | 0.114x | +177.99% |
| 2008-12-31 | AU$48.70 Million | AU$-7.14 Million | -0.147x | +5.45% |
| 2007-12-31 | AU$60.07 Million | AU$-9.31 Million | -0.155x | -146.03% |
| 2006-12-31 | AU$37.05 Million | AU$-2.33 Million | -0.063x | -209.68% |
| 2005-12-31 | AU$3.93 Million | AU$226.00K | 0.057x | +11.37% |
| 2004-12-31 | AU$3.97 Million | AU$205.00K | 0.052x | -79.48% |
| 2002-12-31 | AU$1.36 Million | AU$342.00K | 0.251x | -- |